MICHAEL EHRENFELD, M.D.
TEL-AVIV UNIVERSITY
List of Publications
A.
1.
Books
Eliakim M., Levy M., and Ehrenfeld M.
Recurrent Polyserositis (familial Mediterranean fever, periodic disease).
Elsevier/North-Holland Biomedical Press, 1981.
B.1. Original Articles
1.
Gordon A., Kleinerman H., Ehrenfeld M., and Ehrenfeld E.N.
Parameters of serum binding of thyroxine in hypo-, hyper- and euthyroidism and their
application to the control of therapy.
Israel J. Med. Sci. 7:1029-1034, 1971.
2.
‫מרקאפטופרין בדלקת מיפרקים פסוריאתית‬-6-‫טיפול ב‬
Tur-Kaspa R., Ehrenfeld M., and Eliakim M.
6-Mercaptopurine in psoriatic arthritis.
Harefuah 96:648-650,1979.
3.
,‫תיכונית משפחתית‬-‫הדגמת מכלולים חיסוניים מסיסים בקדחת ים‬
B ‫בזאבת אדמנתית מערכתית ובנשאים של נגיף דלקת הכבד מסוג‬
Zlotnick A., Levo Y., Fischel R., Ehrenfeld M., Levy M., Shouval D., and Eliakim M.
Circulating immune complexes in familial Mediterranean fever, systemic lupus
erythematosus and HBsAg carriers.
Harefuah 97:55-57,1979.
4.
Levo Y., Waisman Y., Ehrenfeld M., Levy M., and Eliakim M.
Lymphocytotoxins in recurrent polyserositis.
Israel J. Med. Sci. 16:203-205,1980.
5.
Bar-Eli M., Ehrenfeld M., Litvin Y., and Gallily R.
Monocyte function in rheumatoid arthritis.
Scand. J. Rheumatol. 9:17-23,1980.
6.
Ehrenfeld M., Levy M., Bar-Eli M., Gallily R., and Eliakim M.
Effect of colchicine on polymorphonuclear leucocyte chemotaxis in human volunteers.
Brit. J. Clin. Pharmacol. 10:297-301,1980.
7.
Levy M., Ehrenfeld M., Levo Y., Fischel R., Zlotnick A. and Eliakim M.
Circulating immune complexes in recurrent polyserositis (familial Mediterranean
fever, periodic disease).
MICHAEL EHRENFELD, M.D.
2
TEL-AVIV UNIVERSITY
J. Rheumatol. 7:886-890,1980.
8.
Steinitz M., Izak G., Cohen S., Ehrenfeld M. and Flechner I.
Continuous production of monoclonal rheumatoid factor by EBV transformed
lymphocytes.
Nature, 287:443-445,1980.
9.
Levo Y.,Waisman Y. and Ehrenfeld M.
Lymphocytotoxins in rheumatoid arthritis.
Israel J. Med. Sci. 16:791-794,1980.
10.
Bar-Eli M, Ehrenfeld M., Levy M., Gallily R. and Eliakim M.
Polymorphonuclear chemotaxis in familial Mediterranean fever.
Am. J. Med. Sci. 281:15-18,1981.
11.
Eisenberg S., Ehrenfeld M., Friedman G. and Friedlander Y.
Risk factors for coronary artery disease in patients with acute myocardial infarction:
Effect of age, sex and ethnicity.
Israel J. Med. Sci. 17:309-317,1981.
12.
Levy M., Ehrenfeld M., Gallily R., and Eliakim M.
Enhanced polymorphonuclear chemotaxis - A common feature of diseases responsive
to colchicine.
Medical Hypotheses 7:15-20,1981.
13.
Bar-Sela S., Ehrenfeld M. and Eliakim M.
Arterial embolism in thyrotoxicosis with atrial fibrillation.
Arch. Int. Med. 141:1191-1192,1981.
14.
Levo Y., Fischel R. and Ehrenfeld M.
Circulating immune complexes in patients with rheumatoid arthritis: Correlation with
disease activity.
J. Rheumtol. 8:851-855,1981.
15.
Zylber-Katz E., Ehrenfeld M., Levy M. and Eliakim M.
Plasma colchicine concentrations in patients with recurrent polyserositis (familial
Mediterranean fever) on long-term prophylaxis.
Arthritis & Rheum. 23:227-231,1982.
16.
Ehrenfeld M., Levy M., Sharon P., Rachmilewitz D. and Eliakim M.
Gastrointestinal effects of long-term colchicine therapy in patients with recurrent
polyserositis (familial Mediterranean fever).
Digestive Dis. and Sciences 27:723-727, 1982.
17.
Levo Y., Ehrenfeld M. and Wollner S.
Serum amyloid P-component levels in rheumatoid arthritis.
Israel J. Med. Sci. 18:715-717,1982.
18.
‫תריסיות עם פרפור פרוזדורים והטיפול המונע בהם‬-‫תסחיפים עורקיים בחולי יתר‬
Bar-Sela S., Ehrenfeld M. and Eliakim M.
MICHAEL EHRENFELD, M.D.
3
TEL-AVIV UNIVERSITY
Prevention of arterial embolism in thyrotoxicosis with atrial fibrillation.
Harefuah, 102:349-350,1982.
19.
20.
Ehrenfeld M., Zylber-Katz E. and Levy M.
Acetylator phenotype in rheumatoid arthritis.
Israel J. Med. Sci. 19:368-370,1983.
Ben-Chetrit E., Naparstek Y., Ehrenfeld M. and Eliakim M.
Short course of Synacthen therapy as an adjunct in the management of rheumatoid
arthritis.
Clin. Rheumatology 4:155-160,1985.
21.
Pines A., Ehrenfeld M., Fisman E.Z., Kaplinsky N., Samra Y., Ronnen M. and
Kellermann J.J.
Mitral valve prolapse in psoriatic arthritis.
Arch. Intern. Med. 146:1371-1373,1986.
22.
Brautbar C., Naparstek Y., Yaron M. Amar A., Ehrenfeld M., Eliakim M., Bentwich
Z., Cohen T., Korman S.H. and Albert E.D.
Immunogenetics of rheumatoid arthritis in Israel.
Tissue Antigens, 28:8-14, 1986.
23.
Ehrenfeld M., Levy M., Margalioth E.J. and Eliakim M.
The effects of long-term colchicine therapy on male fertility in patients with familial
Mediterranean fever.
Andrology, 18:420-426, 1986.
24.
Zimran A., Rudensky B., Kramer M.R., Tedesco F., Ehrenfeld M., Raz R., Greif Z.,
Gelber M., Lishner M, Golan E.R. and Hershko C.
Hereditary complement deficiency in survivors of meningococcal disease: High
prevalence of C7/C8 deficiency in Sephardic (Moroccan) Jews.
Q. J. Med., 63:349-358,1987.
25.
Ehrenfeld M., Bzezinski A., Levy M. and Eliakim M.
Fertility and obstetric history in patients with familial Mediterranean fever on longterm colchicine therapy.
Brit. J. Obst. Gynec., 94:1186-1191,1987.
26.
Bank I., Roth D., Book M., Guterman A., Shnirrer I., Block R., Ehrenfeld M.,
Langevitz P., Brenner H. and Pras M.
Expression and functions of very late antigen-1 in inflammatory joint diseases.
J. Clin. Immunol. 11:29-38,1991.
27.
Meirow D., Anteby S.O., Ehrenfeld M., Barak V. and Pras M.
Serum CA-125 in familial Mediterranean fever.
J. of Tumor Marker Oncology 6:31-37,1991.
28.
Livneh A., Behar E., Many A., Ehrenfeld M., Gazit E. and Diamond B.
Lupus anti-DNA antibodies bearing the 8.12 idiotype appear to be somatically
mutated.
J. Clin. Immunol. 12:11-16,1992.
MICHAEL EHRENFELD, M.D.
29.
4
TEL-AVIV UNIVERSITY
Fishman P., Kamashta M., Ehrenfeld M., Vianna J., Hughes G.R.V., Sredni D.,
Zigelman R., Sabo G. and Shoenfeld Y.
Interkeukin-3 immunoassay in systemic lupus erythematosus patients: Preliminary
data.
Int. Arch. Allergy Immunol. 100:215-218,1993.
____________________________________________________________________
30.
Vitali C., Bombardieri S., Moutsopoulos H.M., ... Ehrenfeld M., et al.
Preliminary criteria for the classification of Sjogren’s syndrome. Results of an EEC
prospective concerted action.
Arthritis & Rheum. 36:340-347,1993.
31.
Adler Y., Zandman-Goddard G., Ravid M., Avidan B., Zemer D., Ehrenfeld M.,
Shemesh J., Tomer Y. and Shoenfeld Y.
Usefulness of colchicine in preventing recurrences of pericarditis.
Am. J. Card. 73:916-917,1994.
32.
Tishler M., Aharon A., Ehrenfeld M., Avni I., Bendet E., Bombardieri S., Yaron M.
and Shoenfeld Y.
Sjogren’s Syndrome in Israel: Primary versus secondary disease.
Clin. Rheum. 13:438-441,1994.
33.
Vitali C., Moutsopoulos H.M., Bombardieri S. … Ehrenfeld M. … et al.
The European Community study group on diagnostic criteria for Sjogren’s syndrome.
Sensitivity and specificity of tests for ocular and oral involvement in Sjogren’s
syndrome.
Ann. Rheum.Dis. 53:637-647,1994.
34.
Slater P.E., Ben-Zvi T., Fogel A., Ehrenfeld M. and Ever-Hadani S.
Absence of an association between rubella vaccination and
underimmune postpartum women.
Vaccine, 13:1529-1532,1995.
arthritis
in
35.
Levy Y., George J., Hojnic M., Ehrenfeld M., Lorber M., Bombardieri S. and
Shoenfeld Y.
Comparison of clinical and laboratory parameters for systemic lupus erythematosus
activity in Israelis versus Europeans.
Isr. J. Med. Sci. 32:100-104,1996.
36.
Kanety H., Shimon I., Ehrenfeld M., Israeli A., Pariente C. and Karasik A.
Insulin-like growth factor I and its binding proteins 3 and 4 are increased in human
inflammatory synovial fluid.
J. Rheumatol. 23: 815-818,1996.
37.
Ehrenfeld M., Buskila D., Tishler M., Lorber M. and Shoenfeld Y.
Rheumatology in Israel.
Brit. J. Rheumatol. 35:778-780,1996.
MICHAEL EHRENFELD, M.D.
5
TEL-AVIV UNIVERSITY
38.
Gur H., Rapman E., Ehrenfeld M., and Sidi Y.
Clinical manifestations of temporal arteritis: A report from Israel.
J. Rheumatol. 23: 1927-1931,1996.
39.
Katz A., Ehrenfeld M., Livneh A., Bank I., Gur H., Pauzner R., Many A. and
Langevitz P.
Aspergillosis in systemic lupus erythematosus: Report of 3 cases and review of the
literature.
Semin. Arth. Rheum. 26:635-640,1996.
40.
Zurgil N., Gerbat S., Langevitz P., Tishler M., Ehrenfeld M., and Shoenfeld Y.
Intracellular fluorescence polarization measurements by the cellscan system:
Detection of cellular activity in autoimmune disorders.
Isr. J. Med. Sci. 33: 273-279,1997.
41.
Rachima-Maoz C., Langevitz P., Livneh A., Blumstein Z., Sadeh M., Bank I.,Gur H.
and Ehrenfeld M.
High incidence of malignancies in patients with dermatomyositis and
polymyositis:eleven year analysis.
Semin. Arth. Rheum. 27: 319-324,1998.
42.
Yussim E., Schwartz E., Sidi Y., and Ehrenfeld M.
Acute renal failure precipitated by non-steroidal anti-inflammatory drugs (NSAIDs) in
multiple myeloma.
Amer. J. Hematol. 58: 142-144,1998.
43.
Zandman-Goddard G., Blank M., Ehrenfeld M., Gilburd B., Peter J., and Shoenfeld Y.
A comparison of autoantibody production in asymptomatic and symptomatic women
with silicone breast implants.
J. Rheumtol. 26: 73-77,1999.
44.
Gur H., Tchakmakjian L., Ehrenfeld M., and Sidi Y.
Polyarteritis nodosa: A report from Israel.
Amer. J. Med. Sci. 317:238-242,1999.
45.
Gur H., Koren V., Ehrenfeld M., Ben-Bassat I, and Sidi Y.
Rheumatic manifestations preceding adult acute leukemia : Characteristics and
implication on course and prognosis.
Acta Haematol.101:1-6,1999.
46.
Bečvář R, Urbanová V, … Ehrenfeld M., and Pavelka K.
Nabumetone induces less gastrointestinal mucosal changes than diclofenac retard.
Clin. Rheumatol. 18:273-278,1999.
47.
Nesher G, Gur H, Ehrenfeld M, Rubinow A, and Sonnenblick M.
The changing clinical presentation of temporal arteritis in Israel.
Isr.Med.Ass.J. 1:21-24,1999.
MICHAEL EHRENFELD, M.D.
6
TEL-AVIV UNIVERSITY
48.
Ehrenfeld M., Bitzur R., Schneiderman J., Smolinsky A., Sidi Y., and Gur H.
Aortic aneurysms and dissection are not associated with an increased risk for giant cell
arteritis / poymyalgia rheumatica.
Postgrad Med J. 76:409-411,2000.
49.
Bar J, Ehrenfeld M, Rozenman J, Perelman M, Sidi Y, and Gur H.
Pulmonary - renal syndrome in systemic sclerosis.
Semin Arth. Rheum.30:403-410,2001.
50.
Ehrenfeld M, Blank M, Shoenfeld Y, and Hidvegi, M.
AVEMAR (a new benzoquinone -containing natural product) administration interferes
with the Th2 response in experimental SLE and promotes amelioration of the disease.
Lupus 10:622-627, 2001.
51.
Shoenfeld Y, Aron-Maor A, Tanai A, and Ehrenfeld M.
BCG and autoimmunity: Another two-edged sword.
J. Autoimmunity 16:235-240,2001.
52.
Herman, S., Zurgil, N., Langevitz,P., Ehrenfeld, M., and Deutsch, M.
The induction of apoptosis by methotrexate in activated lymphocytes as indicated
by fluorescence hyperpolarization: a possible model for predicting methotrexate
therapy for rheumatoid arthritis patients.
Cell Struct. Funct. 28: 113-122, 2003.
53.
Leiba M, Seligsohn U, Sidi Y, Harats D, Sela B, Griffin JH, Livneh A, Rosenberg N,
Gelernter I, Gur H, and Ehrenfeld M.
Thrombophilic factors are not the leading cause of Thrombosis in Patients with
Behcet’s Disease.
Annals of the Rheumatic Diseases, 63: 1445-1449, 2004.
54.
Herman, S., Zurgil, N., Langevitz, P., Ehrenfeld, M., and Deutsch, M.
The immunosuppressive effect of methotrexate in active rheumatoid arthritis patients
versus its stimulatory effect in non-active patients, as indicated by cytometric
measurements of CD4+ T cell subpopulations.
Immun. Invest, 33: 351-362, 2004.
55.
Scope A., Sadetzki S., Sidi Y., Barzilai A., Trau H., Kaufman B., Catane R.,
and Ehrenfeld M.
A possible association between breast cancer and scleroderma: Report of eight
new cases and summary of the literature.
SKINmed. 5:18-24, 2006.
56.
Shalev T., Haviv Y., Segal E., Ehrenfeld M., Pauzner R., Levy Y., Langevitz P.
and Shoenfeld Y.
Outcome of patients with systemic sclerosis admitted to intensive care unit: A
report of nine cases.
Clin. Exp. Rheumatol. 24: 380-386, 2006.
57.
Shovman O, Zandman-Goddard G, Gilburd B, Blank M, Ehrenfeld M,
MICHAEL EHRENFELD, M.D.
7
TEL-AVIV UNIVERSITY
Bardechevski S, Stojanovich L, Langevitz P, Shoenfeld Y.
Restricted specificity of anti-ribosomal P antibodies to SLE in Israel.
Clin Exp Rheumatol. 24: 694-697,2006.
58.
Rabinovich E., Shinar Y., Leiba M., Ehrenfeld M., Langevitz P., and Livneh A.
Common FMF alleles increase the risk for developing vascular-Behcet's disease.
Scand. J. Rheumatol. 36: 48-52, 2007.
59.
Hassin-Baer S., Levi Y., Langevitz P., Nakar S., and Ehrenfeld M.
Anti-β2-glycoprotein I in Sjogren's syndrome is associated with parkinsonism.
Clin. Rheumatol. 26: 743-747, 2007.
60.
Rishpon A, Wohl Y, Barnea Y, Ehrenfeld M, Weiss J, Klaz I, Brenner S.
Silicone implants and connective tissue disease: 5 cases.
SKINmed .6: 30-34, 2007.
61.
Sherer Y, Shepshelovich D, Shalev T, Haviv Y, Segal E, Ehrenfeld M, Levy Y,
Pauzner R, Shoenfeld Y, Langevitz P.
Outcome of patients having dermatomyositis admitted to the intensive care unit.
Clin. Rheumatol.
2007.
62.
Telekes A, Resetar A, Balint G, Blazso G, Falkay G, Lapis K, Raso E, Szende B,
Ehrenfeld M, Shoenfeld Y, Hidvegi M.
Fermented Wheat Germ Extract (Avemar) Inhibits Adjuvant Arthritis.
Ann NY Acad Sci
2007.
63.
Sherer Y, Cerinic MM, Bartoli F, Blagojevic J, Conforti ML, Gilburd B, Ehrenfeld
M, Shoenfeld M.
Early atherosclerosis and autoantibodies to heat-shock proteins and oxidized LDL in
systemic sclerosis.
Ann NY Acad Sci
2007.
64.
Herman S, Zurgil N, Langevitz P, Ehrenfeld M, Deutsch M.
Methotrexate selectively modulates TH1/TH2 balance in active rheumatoid arthritis
patients.
Clin Exp Rheumatol. 2007
B.2. Case Reports
1.
‫אוליגוריה ממושכת לאחר היפרדות מוקדמת של השיליה‬
Ehrenfeld M. and Viskoper R.J.
Prolonged oliguria following premature separation of the placenta.
Harefuah, 88:26-28,1975.
2.
Ehrenfeld M., Licht A., Stessman J., Yanko L. and Rosenmann E.
Postpartum renal failure due to progressive systemic sclerosis treated with
chronic hemodialysis.
Nephron, 18:175-181,1977.
MICHAEL EHRENFELD, M.D.
8
TEL-AVIV UNIVERSITY
3.
‫תיסמונת דמויית בטן חריפה בשל דימום לדופן הבטן בעקבות טיפול בהיפארין‬
Ehrenfeld M., Penchas S., Mani Y. and Luttwak E.M.
Heparin induced bleeding into the abdominal wall presenting as an acute
abdomen.
Harefuah, 92:259-261,1977.
4.
Ehrenfeld M., Penchas S. and Eliakim M.
Thrombocytosis in rheumatoid arthritis: recurrent arterial thromboembolism and
death.
Annals of the Rheumatic Diseases, 36:579-581, 1977.
5.
Ehrenfeld M., Urowitz M.B. and Platts M.E.
Selective C4 deficiency, systemic lupus erythematosus and Whipple’s disease.
Annals of the Rheumatic Diseases, 43:91-94, 1984.
6.
Harats N., Ehrenfeld M., Shalit M. and Lijovetzky G.
Gold-induced granulomatous hepatitis.
Israel J. Med. Sci. 21:753-756,1985.
7.
Ehrenfeld M., Nesher R. and Merin S.
Delayed onset chloroquine retinopathy.
Brit. J. Ophthalmol. 70:281-283,1986.
8.
Ehrenfeld M., Samra Y. and Kaplinsky N.
Acne conglobata and arthritis: Report of a case and review of the literature.
Clinical Rheumatology, 5:407-409, 1986.
9.
‫ תאור מקרה‬- ‫תרומבוציטופניה קשה בברוצלוזיס חד‬
Shaked Y., Samra Y. and Ehrenfeld M.
Severe thrombocytopenia in acute brucellosis.
Harefuah, 114:386, 1988.
10.
‫ תאור מקרה‬:‫מלריה ממארת חשודה ל"מלריה של שדות תעופה" בישראל‬
Shpilberg O., Shaked Y., Stroh C., Ehrenfeld M. and Samra Y.
Suspected airport malaria in Israel: Case report.
Harefuah. 115:117-119,1988.
11.
Shpilberg O., Friedman B., Azaria M., Engelberg S., Apter S. and Ehrenfeld M.
Primary striated muscle lymphoma presenting in an amputation stump.
Israel J. Med. Sci. 25:116-117,1988.
12.
Ehrenfeld M., Asman A., Shpilberg O. and Samra Y.
Cardiac tamponade as the presenting manifestation of systemic lupus
erythematosus.
Am. J. Med. 86:626-627,1989.
13.
Ehrenfeld M., Shpilberg O., Berkowitz M. and Samra Y.
MICHAEL EHRENFELD, M.D.
9
TEL-AVIV UNIVERSITY
Hairy cell leukemia with an autoimmune syndrome, paraproteinemia and
cryoglobulinemia.
South. Med. J. 82:1552-1554,1989.
14.
Shpilberg O., Ehrenfeld M., Abramowich D., Samra Y. and Bat L.
Ergotamine - induced solitary rectal ulcer.
Postgrad. Med. J. 66:483-485,1990.
15.
Ziv R., Schewach-Millet M., Trau H., Ehrenfeld M., Samra Y. and Asman A.
Alopecia universalis in a patient with Marfan’s syndrome.
Isr. J. Med. Sci. 26:705-707,1990.
____________________________________________________________________
16.
Gur H. and Ehrenfeld M.
The benign long term effect of cholesterol crystal synovial cysts.
Clin Rheum. 13:537-542,1994.
17.
Gur H., Ehrenfeld M. and Izsak E.
Pleural effusion as a presenting manifestation of giant cell arteritis.
Clin. Rheum. 15:200-203,1996.
18.
Ehrenfeld M., and Gur H.
Resorptive arthropathy in rheumatoid arthritis.
Ann. Rheum. Dis. 57: 19,1998.
19.
Koren W, Koren E, Nakash N, Ehrenfeld M, and Gur H.
Rhabdomyolysis associated with Clozapine treatment in a patient with decreased
calcium-dependent potassium permeability of cell membranes.
Clin. Neuropharmacol. 21: 262-264,1998.
20.
Zandman-Goddard G, Ehrenfeld M, Levy Y, and Tal S.
Diffuse alveolar hemorrhage in systemic lupus erythematosus.
IMAJ 4:470,2002
B.3. Review Articles And Editorials
1.
‫דלקת מיפרקים פסוריאתית‬
Tur-Kaspa R., Ehrenfeld M. and Eliakim M.
Psoriatic arthritis.
Harefuah, 96:668-670,1979.
2.
‫פניצילאמין‬
Ehrenfeld M.
D-penicillamine.
Harefuah, 112:362-364,1987.
3.
Ehrenfeld M. and Levartowsky D.
Serum amyloid A protein (SAA) and sarcoidosis.
MICHAEL EHRENFELD, M.D.
10
TEL-AVIV UNIVERSITY
Isr. J. Med. Sci. 25:418-420,1989.
4.
____________________________________________________________________
‫שיתלי סליקון להגדלת שדיים ומחלות אוטואימוניות‬
Zandman-Goddard G., Ehrenfeld M. and Shoenfeld Y.
Silicone implants for breast augmentation and autoimmune disease.
Harefuah, 125:360-364,1993.
5.
‫גבישי כולסטרול ודלקת מיפרקים‬
Gur H. and Ehrenfeld M.
Cholesterol crystal arthropathy.
Harefuah, 126:602-604,1994.
6.
‫ מדדים לאיבחון תיסמונת סיוגרן‬:‫קונסנסוס‬
Bendet E., Ehrenfeld M., Avni I., Tishler M., Macadezob S., Kronenberg J. and
Shoenfeld Y.
Consensus: Diagnostic criteria for Sjogren’s syndrome.
Harefuah, 127:342-344,1994.
7.
?‫ או אגדה‬,‫ צרוף מקרים‬,‫ האם סובב ומסובב‬:‫שיתלי סיליקון בשדיים ואוטואימוניות‬
Ehrenfeld M. and Shoenfeld Y.
Silicone breast implants and autoimmune disease: causation, accidental
association of fallacy?
Harefuah, 134: 361-364,1998.
8.
‫ ומעורבות מיפרקים‬B - 91 ‫וירוס‬-‫הזיהום בפארוו‬
Aviram R., Sidi Y., and Ehrenfeld M.
Rheumatic aspects of parvovirus B-19 infection.
Harefuah, 134: 542-545,1998.
9.
‫היפראוסטוזיס אידיופתי מפושט‬
Segal A., Ehrenfeld M., and Ganel A.
Diffuse idiopathic skeletal hyperostosis ( DISH ).
Harefuah,135: 382-387,1998.
10.
Ehrenfeld M., Gur H., and Shoenfeld Y.
Rheumatic manifestations of hematologic disorders.
Curr. Opin. Rheumatol. 11: 62-67,1999.
11.
Ehrenfeld M., Langevitz P., and Shoenfeld Y.
‫ציטוקיניים במחלות מיפרקים דלקתיות‬-‫טיפולים אנטי‬
Anti-cytokine therapy in inflammatory joint disease.
Harefuah, 137:120-124,1999.
12.
Ehrenfeld M, Papa M, and Adar R.
Autoimmune mechanisms in Buerger’s disease.
Crit. Ischemia 11:6-13,2001.
13.
Ehrenfeld M, and Shoenfeld Y.
Malignancies and autoimmune rheumatic diseases.
MICHAEL EHRENFELD, M.D.
11
TEL-AVIV UNIVERSITY
J. Clin. Rheumatol.7:47-50,2001.
14.
Abu-Shakra M, Buskila D, Ehrenfeld M, and Shoenfeld Y.
Cancer and Autoimmunity: Autoimmune and rheumatic features in patients with
malignancies.
Ann. Rheum Dis.60:433-440,2001.
15.
Leiba M, Sidi Y, Gur H, Leiba A, and Ehrenfeld M.
Behcet’s disease and thrombophillia.
Ann. Rheum. Dis.60:1081-1085,2001.
16.
Ehrenfeld M, Abu-Shakra M, Buskila D, and Shoenfeld Y.
The dual association between lymphoma and autoimmunity.
Blood Cells, Molecules, and Diseases 27:750-756,2001.
17.
Abu-Shakra M, Ehrenfeld M, and Shoenfeld Y.
SLE and cancer: Are they positively associated?
Lupus 11:137-144, 2002.
18.
Zandman-Goddard G, Blank M, Sherer Y, Ehrenfeld M, Chapman J, Orbach H,
Gilburd B, Krause I, and Shoenfeld Y.
10th International Congress on antiphospholipid antibodies – summary.
Autoimmunity Rev. 2:79-85,2003.
19.
Molina V, and Ehrenfeld M.
Environmental factors in autoimmune diseases, February 4-5, 2003, Durham,
NC, USA.
Autoimmunity Rev. 2:284-289, 2003. &
(www.rheuma21st.com/archives/report_env_factors_molina.html).
20.
Bar-Meir E, Ehrenfeld M, and Shoenfeld Y.
Silicone gel breast implants and connective tissue disease - a comprehensive
review.
Autoimmunity 36:193-197,2003.
21.
Leiba M, and Ehrenfeld M.
Behcet’s disease: Current therapeutic perspectives.
Curr. Treat. Cardiovasc. Dis. 2005.
D.
1.
Chapters In Books
Bar-Eli M., Levy M., Ehrenfeld M., Eliakim M. and Gallily R.
Phagocyte function in familial Mediterranean fever.
In: Macrophages and Lymphocytes, Part B, pp. 341-350.
Eds. Escobar M.R. and Friedman H., Planum Press, New-York, 1980.
MICHAEL EHRENFELD, M.D.
TEL-AVIV UNIVERSITY
12
2.
Levo Y.,Waisman Y., Fischel R. and Ehrenfeld M.
Circulating immune complexes and cold reacting lymphocytotoxins in
rheumatoid arthritis.
In: Progress in Rheumatology, pp. 17-21.
Ed. Machtey I., J. Wright - PSG, Great Britain,1982.
3.
Ehrenfeld M.
Arthritic diseases affecting the spine.
In: Y. Floman (Ed.) Disorders of the Lumbar Spine:
Aspen Publishers Inc. U.S.A. and Freund Publishing House, Ltd. Israel, pp. 711741,1990.
4.
Ehrenfeld M.
Diffuse idiopathic skeletal hyperostosis (DISH).
In: Y. Floman (Ed.) Disorders of the Lumbar Spine:
Aspen Publishers Inc. U.S.A. and Freund Publishing House, Ltd. Israel. pp. 743748, 1990.
5.
Ehrenfeld M., and Shoenfeld Y.
Views from a different perspective: Hematology and Oncology in Rheumatology.
Oxford Textbook of Rheumatology.
Oxford University Press, 1993 (1st. Ed.) & 1997 (2nd. Edition).
____________________________________________________________________
6.
Shoenfeld Y., and Ehrenfeld M.
Hematologic manifestations.
In: Schur, PH.(Ed.). The Clinical
Erythematosus, 2nd Ed.
J.P. Lippincott Comp., U.S.A. 1996.
Management
of
Systemic
Lupus
7.
Ehrenfeld M., and Shoenfeld Y.
Hematologic manifestations of rheumatoid arthritis.
In: Up-to-Date. A Computer leased program on CD-ROM.
Edited by Schur PH. 1997.
8.
Ehrenfeld M., Pras M., and Shoenfeld Y.
Is familial Mediterranean fever an autoimmune disease or an immune mediated
condition ?
In: Sohar E., Gafni J., and Pras M, eds.
Proceedings of the 1st. International Conference on familial Mediterranean fever
(FMF). Jerusalem. Freund Publishing House 1997.
9.
Zurgil N, Gerbat S, Langevitz P, Tishler M, Ehrenfeld M, Kaufman M, Deutsch
M, and Shoenfeld Y.
Detection of cellular activity in autoimmune disorders by Cellscan system.
In: The Decade of Autoimmunity. Ed. Shoenfeld Y.
Elsevier Science B.V. Amsterdam, The Netherlands; 1999, pp. 295-304.
MICHAEL EHRENFELD, M.D.
10.
13
TEL-AVIV UNIVERSITY
Ehrenfeld M, Amital H, and Shoenfeld Y.
Cytokines, Th1/Th2 and adhesion molecules in the antiphospholipid syndrome.
In: The Antiphospholipid Syndrome II: Autoimmune Thrombosis.
Ed. Asherson RA, Cervera R, Piette J-C, and Shoenfeld Y.
Elsevier Science. Amsterdam, The Netherlands; 2002, pp. 107-112.
MICHAEL EHRENFELD, M.D.
E.
14
TEL-AVIV UNIVERSITY
Papers Presented At Scientific Meetings and Abstracts
E.2. Published as Abstracts
1.
Ehrenfeld M., Rubinger D., Friedman G. and Eisenberg S.
Hyperlipidemia, diabetes and hypertension in patients with acute myocardial
infarction.
Biennial Meeting of the Israel Society of Internal Medicine, Haifa, Israel, 1975.
2.
Ehrenfeld M., Penchas S., and Eliakim M.
Thrombocytosis in rheumatoid arthritis: Recurrent arterial thromboembolism and
death.
International Seminar on Treatment of Rheumatic Diseases, Tel-Aviv, Israel,
1977.
3.
Levy M., Cohen M.M.,Yaffe C., Ehrenfeld M. and Eliakim M.
Long-term follow-up of colchicine treated patients with familial Mediterranean
fever: Testicular function, cytogenetic and absorption studies.
Biennial Meeting of the Israel Society of Internal Medicine, Herzeliya, Israel,
1978.
4.
Ehrenfeld M., Bar-Eli M., Levy M. and Eliakim M.
Chemotaxis of polymorphonuclear leucocytes derived from familial
Mediterranean fever patients.
Biennial meeting of the Israel Society of Internal Medicine, Herzeliya, Israel,
1978.
5.
Tur-Kaspa R., Ehrenfeld M. and Eliakim M.
Treatment of psoriatic arthritis with 6-Mercaptopurine.
Biennial meeting of the Israel Society of Internal Medicine, Herzeliya, Israel,
1978.
6.
Levy M., Ehrenfeld M., Bar-Eli M., Gallily R. and Eliakim M.
Polymorphonuclear leukocyte chemotaxis: Effect of colchicine in human
volunteers and findings in diseases responding to colchicine therapy.
81st Annual Meeting of the American Society for Clinical Pharmacology and
Therapeutics, San Francisco, U.S.A.,1980.
Clin. Pharmacol. & Therap. 27:266,1980.
7.
Levo Y., Levy M., Ehrenfeld M., Waisman Y., Fischel R. and Eliakim M.
Circulating immune complexes and lymphocytotoxins in recurrent polyserositis
(familial Mediterranean fever).
44th Annual meeting of the American Rheumatism Association, Atlanta/Ga.,
U.S.A.
Arthritis & Rheum. 23:710-711,1980.
MICHAEL EHRENFELD, M.D.
15
TEL-AVIV UNIVERSITY
8.
Steinitz M., Izak G., Cohen S. and Ehrenfeld M.
Continuous production of human monoclonal antibody by in-vitro EBV
transformed lymphocytes.
Joint Meeting of the 18th Congress of the International Society of Hematology
and 16th Congress of the International Society of Blood Transfusion, Montreal,
Canada, 1980, p. 83, Abst.#332.
9.
Levo Y., Waisman Y., Fischel R. and Ehrenfeld M.
Circulating immune complexes and cold reacting lymphocytotoxins in
rheumatoid arthritis.
2nd International Seminar on Treatment of Rheumatic Diseases, Israel, 1980,
p.25.
10.
Floman Y.,Yosipovitch Z., Ehrenfeld M. and Makin M.
Articular manifestations of familial Mediterranean fever.
48th Annual Meeting - The American Academy of Orthopedic Surgeons, LasVegas, U.S.A., 1981, p.148.
11.
Ehrenfeld M., Zylber-Katz E., Levy M. and Eliakim M.
Plasma colchicine concentration in patients with recurrent polyserositis (familial
Mediterranean fever) on long-term prophylaxis.
15th International Congress of Rheumatology, Paris, France, 1981, Abstract #304;
Revue du Rheumatism et des Maladies Osteoarticulaires, June 1981.
Annual Meeting - The Royal College of Physicians and Surgeons of Canada,
Montreal, Canada, 1981 14:236, Abstract #319.
12.
Tenenbaum J., Ehrenfeld M. and Miller M. Intravenous colchicine in the
treatment of severe Lofgren’s syndrome. (Erythema nodosum-arthritis-bilateral
hilar lymphadenopathy).
8th Pan-American Congress of Rheumatology, Washington, D.C., U.S.A., 1982.
Arthritis & Rheum. 25:S148, 1982.
13.
Ehrenfeld M., Levy M., Sharon P., Rachmilewitz D., and Eliakim M.
Malabsorption on long-term colchicine therapy in recurrent polyserositis
(familial Mediterranean fever).
8th Pan-American Congress of Rheumatology, Washington, D.C., U.S.A,1982.
Arthritis & Rheum. 25:S141,1982.
14.
Levo Y. and Ehrenfeld M.
Serum amyloid P-component levels in rheumatoid arthritis.
8th Pan-American Congress of Rheumatology, Washington, D.C., U.S.A., 1982.
Arthritis & Rheum. 25:S123, 1982.
15.
Ben Chetrit E., Naparstek Y.,Ehrenfeld M, and Eliakim M.
Short course Synacthen therapy as an adjunct in the management of rheumatoid
arthritis.
Biennial meeting of the Israel Society of Internal Medicine, Tel-Aviv, Israel,
1983.
MICHAEL EHRENFELD, M.D.
16
TEL-AVIV UNIVERSITY
16.
Eliakim M., Levy M. and Ehrenfeld M.
Effect of colchicine in recurrent polyserositis (familial Mediterranean fever).
1st International Symposium on familial Mediterranean fever (periodic disease),
Istanbul, Turkey, 1983.
17.
Ehrenfeld M., Naparstek Y., Yaron M., Bentwich Z. and Brautbar C.
HLA antigens in rheumatoid arthritis.
3rd International Seminar on Treatment of Rheumatic Diseases.
Jerusalem, Israel, 1983.
18.
Harats N., Shalit M. and Ehrenfeld M.
Gold-induced granulomatous hepatitis.
3rd International Seminar on Treatment of Rheumatic Diseases
Jerusalem, Israel, 1983.
19.
Ehrenfeld M., Nesher R. and Merin S.
Delayed onset chloroquine retinopathy.
3rd International Seminar on Treatment of Rheumatic Diseases.
Jerusalem, Israel, 1983.
Also in: Ophthalmology Digest, 3:3, 1987.
20.
Ehrenfeld M., Pines A., Fisman Z., Kaplinsky N., Samra Y. and Kellerman J.
Mitral valve prolapse in psoriatic arthritis.
16th International Congress of Rheumatology, Sydney, Australia 1985 (p753) and
the 4th International Symposium on Psoriasis, Stanford, Ca, U.S.A., 1986.
Also in: Cardiology: Rapid Literature Review 9-10:77, 1986.
21.
Ehrenfeld M., Shpilberg O., Rosenblum Y., Asman A., Many A. and Samra Y.
Systemic lupus erythematosus and infection-A retrospective study.
14th World Congress of the Israel Medical Association, Jerusalem, Israel, 1988,
and the 2nd International Conference on Systemic Lupus Erythematosus,
Singapore, 1989.
22.
Ehrenfeld M., and Schewach-Millet M.
Treatment of psoriatic arthritis with Auranofin: An open study.
4th International Symposium on the Treatment of Psoriasis and PsoriasisArthritis, Israel, 1989.
23.
Bank I., Roth D., Ehrenfeld M., and Pras M.
Expression of the VLA-1 activation antigen on the surface of synovial T cells in
arthritis: lack of disease specificity.
AAP/ASCI/AFCR National Meeting, Washington D.C., 1989.
24.
Linve A., Bachar E., Gazit E., Ehrenfeld M. and Many A.
Anti-DNA antibodies bearing 8.12 idiotype are being formed in response to a
specific antigen.
7th Israel Medical Week (MEDAX 89) Jerusalem, Israel, 1989.
MICHAEL EHRENFELD, M.D.
17
TEL-AVIV UNIVERSITY
25.
Ehrenfeld M.
Inbar - The Israeli Arthritis Foundation.
12th European Congress of Rheumatology, Budapest, Hungary, 1991.
26.
Ehrenfeld M., Pauzner R., Samra Y., Blumstein Z., and Modan B.
Progressive systemic sclerosis and malignancy.
15th World Congress of the Israel Medical Association and the 8th Israel
Medical Week (Medax 1991), Jerusalem, Israel,1991.
27.
Gur H., and Ehrenfeld M.
Cholesterol crystals in inflammatory arthritis.
The 1st Hungarian-Israeli Scientific Meeting Tel Aviv, Israel, 1993.
28.
Ehrenfeld M., Fogel A., Ben-Zvi T., Slater P.E. and Wolinsky J.S.
Rubella vaccination and chronic arthropathy: Preliminary results of a large
historical prospective study.
57th Annual Scientific meeting of the American College of Rheumatology, San
Antonio, USA, 1993.
____________________________________________________________________
29.
Ben Yehuda A., Yarshansky O., Baar E., Ehrenfeld M., and Machtei EE.
Periodontal disease and psoriatic arthritis.
Dental Res. 73(4), 1994. (Abst. #45).
30.
Shimon I., Kanety H., Ehrenfeld M., Israeli A., Pariente C., and Karasik A.
IgF-I and IGFBP-3 & 4 are increased in synovial fluids from inflammatory
arthritis.
The Annual meeting of the Israel Endocrine Society, Tel-Aviv, Israel 1995. (IES
annual prize for best clinical abstract).
31.
Ehrenfeld M., Asman A., and Shpilberg O.
Pericarditis in SLE: A retrospective analysis.
4th International Conference on Systemic lupus Erythematosus.
Jerusalem, Israel 1995. Lupus, 4:Suppl 2, 148, 1995.
32.
Katz A., Ehrenfeld M., Langevitz P., Livneh A., Bank I., Gur H., Pauzner R.,
and Many A.
Invasive aspergillosis in systemic lupus erythematosus.
4th International Conference on Systemic Lupus Erythematosus, Jerusalem,
Israel 1995. Lupus, 4:Suppl 2, p 86,1995.
33.
Ehrenfeld M., Langevitz P., Katz A., Bank I., Gur H., and Many A.
Opportunistic infections in connective tissue diseases.
13th European Congress of Rheumatology.
Amsterdam, The Netherlands, 1995.
in Rheumatology in Europe 24: Suppl 3, C.106, 1995.
MICHAEL EHRENFELD, M.D.
18
TEL-AVIV UNIVERSITY
34.
Ehrenfeld M., Rachima, C., Gur, H., Livneh, A., Bank, I., Sadeh, M., and
Langevitz P.
Extremely high incidence of malignancies in patients with dermatomyositis: A
ten year analysis.
The 6th Northern Lights Neuroscience Symposium on inflammatory myopathies.
Svalbard, Norway, 1995.
35.
Ehrenfeld, M., Buskila, D., Tishler, M., Lorber, M., and Shoenfeld, Y.
Rheumatology in Israel.
The 27th Congress of the German Rheumatological Society, Bamberg, Germany,
1996.
36.
Zandman-Goddard, G., Blank, M., Ehrenfeld, M., Gilburd, B., Peter, J.,
Gershwin, E.M., and Shoenfeld, Y.
A comparison of autoantibody production in asymptomatic and symptomatic
women with silicone breast implants.
60th Annual Scientific meeting of the American College of Rheumatology,
Orlando, Florida, USA, 1996.
37.
Romano A., Ehrenfeld M., Gamus D., and Savion N.
Clinical and experimental features of hydroxychloroquine: A novel application as
an antiviral agent in HSV an zoster stromal keratitis.
2nd International Symposium on Experimental and Clinical Ocular Pharmacology
and Pharmaceutics. Munich, Germany. 1997.
38.
Gur H., Tchakmakjian L., Ehrenfeld M., and Sidi Y.
Polyarteritis nodosa: Association with familial Mediterranean fever (FMF) in
Israeli patients.
1st International Conference on familial Mediterranean fever (FMF).
Jerusalem, Israel,1997.
39.
Ehrenfeld M., Bitzur R., Schneiderman J., Smolinsky A., and Sidi Y.
Thoracic aortic aneurysms are not associated with an increased risk for giant cell
arteritis.
61st Annual meeting of the American College of Rheumatology;
Washington DC, USA, 1997.
40.
Gur H., Koren V., Ehrenfeld M., and Sidi Y.
Characteristics of adult acute leukemia with rheumatic manifestations.
61st Annual meeting of the American College of Rheumatology;
Washington DC, USA,1997.
41.
Adler Y., Guindo J., Rodriguez A., .... Ehrenfeld M., et al.
Recurrent pericarditis and colchicine: 10-years of experience.
46th Annual Scientific Session of the American College of Cardiology, Anaheim,
USA, 1997.
JACC , 29: Suppl. A; 24A- Abst. 907-166, 1997.
Also at the 1st International Conference on familial Mediterranean fever (FMF),
Jerusalem, Israel, Abst. # 9,1997.
MICHAEL EHRENFELD, M.D.
19
TEL-AVIV UNIVERSITY
42.
Ehrenfeld M, and Harats D.
Serum lipoprotein (a) level in patients with systemic lupus erythematosus.
5th International Conference on SLE; Cancun, Mexico, 1998.
43.
Ehrenfeld M.
Novel approaches in the treatment of rheumatic diseases: New NSAIDs, and
TNF-α blockers.
Joint Israeli-Hellenic International Meeting for the 10th Anniversary of the Israeli
Society for Surgery of the Hand. Jerusalem, Israel, 2000.
44.
Ehrenfeld M, Blank M, and Shoenfeld Y.
AVEMAR - (MSC), a new benzoquinone -containing natural product,
immunomodulates experimental model of systemic lupus erythematosus.
Joint Meeting of the Israeli Societies of Rheumatology, and Allergy and Clinical
Immunology, Dead Sea, Israel, 2000; IMAJ 2000;2 (Suppl 2):32. and the 3rd
International Congress on Autoimmunity, Geneva, Switzerland, 2002.
Autoimmunity Rev. 2002; S53. & the 10th International Congress on
Antiphospholipid Antibodies, Sicily, Italy, 2002.
45.
Ehrenfeld M, Blank M, and Shoenfeld Y.
Antipolymer antibody reactivity in symptomatic and asymptomatic women with
silicone breast implants.
Joint Meeting of the Israeli Societies of Rheumatology, and Allergy and Clinical
Immunology, Dead Sea, Israel, 2000. IMAJ 2000;2 (Suppl 2):32.
46.
Bar J, Ehrenfeld M, Rozenman J, Perelman M, Sidi Y, and Gur H.
Pulmonary - renal syndrome in systemic sclerosis: case report and analysis of 10
additional reported cases.
Joint Meeting of the Israeli Societies of Rheumatology, and Allergy and Clinical
Immunology, Dead Sea, Israel, 2000. IMAJ 2000;2(Suppl 2):29.
47.
Renaudineau Y, Blank M, Korenberg A, Ehrenfeld M, Grinbaume E, Youineau
P, and Shoenfeld Y.
Tissue-factor expression by endothelial cells upon exposure to anti-endothelial
cell antibodies directed to different target antigens.
Joint Meeting of the Israeli Societies of Rheumatology, and Allergy and Clinical
Immunology, Dead Sea, Israel, 2000. IMAJ 2000;2(Suppl 2):40.
48.
Rauova L, Gilburd B, Blank M, Goldberg I, Kopolovic J, Ehrenfeld M.
Rovensky Y, and Shoenfeld Y.
Anti-dsDNA anti-idiotypic activity as the main mechanism of IVIG effect in
SLE.
65th. National Annual Scientific meeting of the American College of
Rheumatology, San-Francisco, California, U.S.A. Arthritis & Rheum. 2001.
49.
Leiba M, Zeligshon U, Sidi Y, Haratz D, Sela B, Gur H, Livneh A, and
Ehrenfeld M.
Variables associated with vascular thrombosis in Behcet’s disease.
10th International Conference on Behcet’s Disease, Berlin, 2002. pp.62, abst.022.
MICHAEL EHRENFELD, M.D.
20
TEL-AVIV UNIVERSITY
50.
Ehrenfeld M, Amital H, and Shoenfeld Y.
Cytokines, Th1/Th2 and adhesion molecules in the antiphospholipid syndrome
(APS).
10th International Congress on Antiphospholipid Antibodies, Sicily, Italy, 2002.
51.
Ehrenfeld M, Bar-Natan M, Sidi Y, and Schwartz E.
Antiphospholipid antibodies associated with severe malaria infection.
10th International Congress on Antiphospholipid Antibodies, Sicily, Italy, 2002,
and the 4th Asia Pacific Travel Health Conference, Shanghai, China, 2002.
52.
Bank I, Goldstein I, Ben-Horin S, Langevitz P, Ehrenfeld M, Koltakov A,
Rosenthal E, and Chess L.
Anti-tumor necrosis factor alpha therapy in rheumatoid arthritis is associated with a
partial decrease of alpha1beta1 integrin (VLA-1) expressing memory TH1 cells in the
peripheral blood of treatment responsive patients.
Annual European Congress of Rheumatology, Berlin, 2004.
53.
Ben-Horin S, Goldstein I, Koltakov A, Langevitz P, Ehrenfeld M, Rosenthal E,
Chess L, and Bank I.
Anti tumor necrosis factor alpha decreases the memory VLA-1+Th1 subset in
vitro and in vivo while increasing CD4+CD25 high (regulatory) T cells.
Annual meeting of the Israeli Society of Rheumatology, Tiberias, 2004.
54.
Ehrenfeld M, Elad A, Bonita S, Mischari S, Margalit A, and Ziv A.
Teaching risk management to medical interns via simulated patient encounters.
30th Anniversary IUT Conference – Improving University Teaching – Pittsburgh,
Pa. U.S.A., 2005.
55.
Ehrenfeld M.
Familial Mediterranean fever (FMF) - Clinical spectrum and molecular basis.
27th State Meeting (NSW Branch); Australian Rheumatology Association. 2005;
Blue Mountains, NSW, Australia.
56.
Telekes A, Resetar A, Balint G, Blazso G, Falakay G, Lapis K, Raso E, Szende
B, Ehrenfeld M, Shoenfeld Y, Hidvegi M.
A fermented wheat germ extract inhibits adjuvant arthritis in rats.
5th International Congress on Autoimmunity, Sorrento, Italy, 2006.
In: Autoimmunity Reviews , p. 58, December 2006.
57.
Balint G, Apathy A, Gaal M, Telekes A, Resetar A, Blazso G, Falkay G, Szende
B, Paksy A, Ehrenfeld M, Shoenfeld Y, Hidvegi M.
Effect of Avemar – A fermented wheat germ extract – on rheumatoid arthritis.
5th International Congress on Autoimmunity, Sorrento, Italy, 2006.
In: Autoimmunity Reviews , p. 59, December 2006.
58.
Shovman O, Zandman-Goddard G, Gilburd B, Blank M, Ehrenfeld M,
Bardechevski S, Stojanovich L, Langevitz P, Shoenfeld Y.
Restricted specificity of anti-Ribosomal P antibodies to SLE patients in Israel.
5th International Congress on Autoimmunity, Sorrento, Italy, 2006.
In: Autoimmunity Reviews , p. 351, December 2006.
MICHAEL EHRENFELD, M.D.
21
TEL-AVIV UNIVERSITY
59.
Zandman-Goddard G, Tweezer-Zaks N, Shalev T, Levy Y, Ehrenfeld M,
Langevitz P.
A novel overlap syndrome: Systemic sclerosis associated with antiphospholipid
syndrome – a case series.
5th International Congress on Autoimmunity, Sorrento, Italy, 2006.
In: Autoimmunity Reviews , p. 368, December 2006.
60.
Orbach H, Szekanecz Z, Szücs G, Dankơ K, Emmese K, Nagy E, Csépány T,
Zandman-Goddard G, Amital H, Andrea D, Ehrenfeld M, Shoenfeld Y.
Hyperprolactinemia in SLE and other autoimmune diseases.
8th International Cogress on SLE, Shaghai, China, May 2007.
MICHAEL EHRENFELD, M.D.
H.
22
TEL-AVIV UNIVERSITY
Other Publications
1.
Penchas S. and Ehrenfeld M.
Thrombocytosis in rheumatic fever.
Arch. Int. Med.,137:1639,1977. (Letter)
2.
Ehrenfeld M., Miller M., Baum J. and Tenenbaum J.
Intravenous colchicine in acute sarcoid arthropathy.
J. Rheumatol. 11:412-413,1984. (Letter).
3.
Ehrenfeld M., Fisman E.Z. and Pines A.
Mitral valve prolapse in psoriatic arthritis.
Arch. Int. Med., 147:992, 1987. (Letter).
4.
Langevitz P., Kaplinsky N., Ehrenfeld M., and Pras M.
Intractable rheumatoid arthritis - treatment with combined methotrexate,
azathioprine and hydroxychloroquine.
Brit. J. Rheum. 28:271-272, 1989 (Letter).
5.
Shpilberg O., Douer D., Ehrenfeld M., Engelberg S., and Ramot B.
Naproxen - associated fatal acute renal failure in multiple myeloma.
Nephron 55:448-449, 1990 (Letter).
6.
Ehrenfeld M.
Clinical Expert Report for 150 mg daily dosage of Diclofenac Sodium.
7.
Asman A., Ehrenfeld M., Sadeh M., Feldman S., and Samra Y.
Polymyositis and myelodysplastic syndrome.
J. Rheumatol. 18:1272-1274,1991 (Letter).
8.
Shelkovitz-Shiloh I., Ehrenfeld M., Schewach-Millet M., and Feinstein A.
Coexistence of familial systemic lupus erythematosus and localized scleroderma.
Int. J. Dermatol. 31:819-820,1992. (Letter).
____________________________________________________________________
9.
Gur H., Rapman E., Ehrenfeld M. and Sidi Y.
Temporal arteritis in Israel.
J. Rheumatol. 24,1659,1997. (Reply, Letter)
10.
Ehrenfeld M., Buskila D., Tishler M., Lorber M. and Shoenfeld Y.
The contribution of the Rabin Medical Center to the field of Rheumatology.
Brit. J. Rheumatol. 36: 1136,1997 (Reply, Letter).
11.
Ehrenfeld M.
‫ להכות את האוסטאוארתריטיס‬The Arthritis Cure.
‘Matar’ Publishing House, Israel, 1998. (Scientific Editor- book).
MICHAEL EHRENFELD, M.D.
23
TEL-AVIV UNIVERSITY
12.
Ehrenfeld M, and Levy M.
Clinical differences between North African and Iraqi Jews with familial
Mediterranean fever.
Amer. J. Med. Genet. 82:442,1999.(Letter).
13.
Ehrenfeld M, and Adar R.
Rheumatic manifestations in patients with thromboangiitis obliterans (Buerger’s
disease).
J. Rheumatol 27:1818-1819, 2000 (Letter).
14.
Leiba M, Sidi Y, Gur H, Leiba A, Ehrenfeld M.
Behcet’s disease and thrombophilia.
Ann. Rheum. Dis. 61:381,2002 (Letter).